Eiger BioPharmaceuticals, Inc. 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Apr 1, 2016
Insider Transaction Report
Form 4
Bramlage Charles
Director
Transactions
- Award
Stock Option (Right to Buy)
2016-03-28+25,000→ 25,000 totalExercise: $15.75Exp: 2026-03-28→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]The option vests in equal monthly installments over 12 months measured from March 28, 2016 subject to Reporting Person's continuous service status as of each such date.
- [F2]The option is subject to shareholder approval of an amendment to the Celladon Corporation 2013 Equity Incentive Plan. This is a voluntary early filing.